3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
58
Breast Neoplasms
25
Neoplasms
5
Neoplasm Metastasis
3
Leiomyoma
3
Polycystic Ovary Syndrome
2
Neoplasms by Site
2
Endometrial Neoplasms
2
Cardiovascular Diseases
2
Breast Diseases
2
Stage II Prostate Adenocarcinoma
1
Sleep Wake Disorders
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Salivary Gland Neoplasms
1
Salivary Gland Adenoma, Pleomorphic
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatectomy
1
Prostate Cancer With ≤10 Bone Metastases
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Pelvic Pain
1
Ovarian Neoplasms
1
Osteoporosis
1
Oligometastatic Prostate Carcinoma
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Kallmann Syndrome
1
Inflammatory Breast Neoplasms
1
Interventions
Exercise
34
Therapeutics
22
Modafinil
21
Yoga
17
Methylphenidate
16
Psychiatric Rehabilitation
11
Acupuncture Therapy
11
Surveys and Questionnaires
10
Educational Status
9
Walking
8
Early Intervention, Educational
8
Cognitive Behavioral Therapy
8
Ultraviolet Therapy
7
Control Groups
7
Therapeutic Touch
6
Physical Therapy Modalities
6
Exercise Therapy
6
Acceptance and Commitment Therapy
6
Sugars
5
Qigong
5
Counseling
5
Standard of Care
4
Saline Solution
4
Palliative Care
4
Methods
4
Epoetin Alfa
4
Dexamethasone
4
Behavior Therapy
4
Acupressure
4
methyl hydroxyethyl cellulose
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Fatigue
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts